SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-038025
Filing Date
2022-11-18
Accepted
2022-11-18 16:05:40
Documents
18
Period of Report
2022-11-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K achv-8k_20221114.htm   iXBRL 8-K 47182
2 EX-4.1 achv-ex41_55.htm EX-4.1 137458
3 EX-10.1 achv-ex101_54.htm EX-10.1 162077
4 EX-10.2 achv-ex102_53.htm EX-10.2 212998
5 EX-99.1 achv-ex991_6.htm EX-99.1 22042
6 GRAPHIC g0aqixktv34q000001.jpg GRAPHIC 18627
7 GRAPHIC g0aqixktv34q000003.jpg GRAPHIC 4831
  Complete submission text file 0001564590-22-038025.txt   841397

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA achv-20221114.xsd EX-101.SCH 5617
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE achv-20221114_lab.xml EX-101.LAB 20041
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE achv-20221114_pre.xml EX-101.PRE 11945
12 EXTRACTED XBRL INSTANCE DOCUMENT achv-8k_20221114_htm.xml XML 3674
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 221401967
SIC: 2835 In Vitro & In Vivo Diagnostic Substances